Mirum Pharmaceuticals (MIRM) Cash from Operations (2019 - 2026)

Mirum Pharmaceuticals' Cash from Operations history runs 8 years deep, the most recent figure standing at 228763000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 11565.63% year-over-year to 228763000.0; the TTM figure through Mar 2026 stood at 170975000.0 (down 2396.71% YoY), while the FY2025 annual figure was 55827000.0, up 440.7% from the prior year.
• Cash from Operations was 228763000.0 for Q1 2026 at Mirum Pharmaceuticals, down from 6067000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 39681000.0 in Q3 2025 to a low of 228763000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 20805352.94 across 5 years, with a median of 16618000.0 in 2023.
• The sharpest annual moves came in 2025 and 2026: Cash from Operations surged 896.01% in 2025, then slumped 11565.63% in 2026.
• A 5-year view of Cash from Operations shows it stood at 34270000.0 in 2022, then surged by 51.51% to 16618000.0 in 2023, then surged by 69.5% to 5068000.0 in 2024, then surged by 219.71% to 6067000.0 in 2025, then slumped by 3870.61% to 228763000.0 in 2026.
• The last three Cash from Operations figures came in at 228763000.0 (Q1 2026), 6067000.0 (Q4 2025), and 39681000.0 (Q3 2025), per Business Quant data.